NYSE:STE - Steris Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $135.11 +0.31 (+0.23 %) (As of 05/26/2019 10:04 AM ET)Previous Close$135.11Today's Range$134.72 - $136.4852-Week Range$99.14 - $137.60Volume530,435 shsAverage Volume433,624 shsMarket Capitalization$11.43 billionP/E Ratio27.63Dividend Yield1.01%Beta1.06 ProfileAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment install, maintain, upgrade, repair, and troubleshoot services. This segment provides its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, including instrument and endoscope repair and maintenance solutions; and custom process improvement consulting and outsourced sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier products, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization services using gamma, electron beam, and X-ray technologies, as well as ethylene oxide and hydrogen peroxide; and laboratory testing services. It operates a network of approximately 50 facilities. The company was founded in 1985 and is based in Derby, the United Kingdom. Receive STE News and Ratings via Email Sign-up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Surgical appliances & supplies Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNYSE:STE Previous Symbol CUSIP85915210 CIK1624899 Webhttp://www.steris.com/ Phone44-13-3238-7100Debt Debt-to-Equity Ratio0.37 Current Ratio2.27 Quick Ratio1.82Price-To-Earnings Trailing P/E Ratio27.63 Forward P/E Ratio25.11 P/E GrowthN/A Sales & Book Value Annual Sales$2.78 billion Price / Sales4.11 Cash Flow$6.3462 per share Price / Cash Flow21.29 Book Value$37.66 per share Price / Book3.59Profitability EPS (Most Recent Fiscal Year)$4.89 Net Income$304.05 million Net Margins10.93% Return on Equity13.34% Return on Assets8.29%Miscellaneous Employees12,000 Outstanding Shares84,587,000Market Cap$11.43 billion Next Earnings Date8/14/2019 (Estimated) OptionableOptionable Steris (NYSE:STE) Frequently Asked Questions What is Steris' stock symbol? Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE." How often does Steris pay dividends? What is the dividend yield for Steris? Steris declared a quarterly dividend on Monday, May 13th. Investors of record on Wednesday, June 12th will be given a dividend of $0.34 per share on Friday, June 28th. This represents a $1.36 annualized dividend and a yield of 1.01%. The ex-dividend date is Tuesday, June 11th. View Steris' Dividend History. How were Steris' earnings last quarter? Steris PLC (NYSE:STE) released its earnings results on Monday, May, 13th. The medical equipment provider reported $1.53 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.44 by $0.09. The medical equipment provider had revenue of $768 million for the quarter, compared to analysts' expectations of $738.87 million. Steris had a return on equity of 13.34% and a net margin of 10.93%. The company's revenue was up 7.3% on a year-over-year basis. During the same quarter last year, the business earned $1.24 EPS. View Steris' Earnings History. When is Steris' next earnings date? Steris is scheduled to release their next quarterly earnings announcement on Wednesday, August 14th 2019. View Earnings Estimates for Steris. What guidance has Steris issued on next quarter's earnings? Steris updated its FY20 earnings guidance on Monday, May, 13th. The company provided earnings per share (EPS) guidance of $5.28-5.43 for the period, compared to the Thomson Reuters consensus estimate of $5.29. The company issued revenue guidance of +5-6% to $2.92-2.95 billion, compared to the consensus revenue estimate of $2.90 billion. What price target have analysts set for STE? 4 equities research analysts have issued 1-year target prices for Steris' shares. Their forecasts range from $138.00 to $157.00. On average, they expect Steris' stock price to reach $148.75 in the next twelve months. This suggests a possible upside of 10.1% from the stock's current price. View Analyst Price Targets for Steris. What is the consensus analysts' recommendation for Steris? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Steris. What are Wall Street analysts saying about Steris stock? Here are some recent quotes from research analysts about Steris stock: 1. According to Zacks Investment Research, "Over the past year, STERIS has been outperforming its industry.The company’s favorable underlying market trends along with new product and service offerings buoy optimism. Growth in free cash flow reserve is indicative of the company’s strong cash balance. The company raising its constant currency organic revenue growth expectations for fiscal 2019 is indicative of brighter prospects. Last December, STERIS announced a restructuring plan that involved shutting down of two manufacturing units along with product rationalization. It has also made certain divestments and organizational changes, which are expected to better align with its operations. However, currently customer consolidation scenario is raising concern, which is likely to adversely impact STERIS. The competitive landscape and weak cost reduction initiatives of STERIS continue to be causes of concern for the company." (4/30/2019) 2. JMP Securities analysts commented, "We reiterate our Market Outperform rating on STERIS and price target of $135 following the release of F3Q19 results. STE announced quarterly results following Monday’s close, and will hold its call at 10 a.m. ET today; we will look for more color on guidance, as well as revenue and earnings drivers at that time. Our $135 price target is based on 23-24x our CY20 EPS estimate of $5.70. Our multiple reflects a slight discount to a group of mid-to-high single-digit growing, mid- cap MedTech peers." (2/14/2019) Has Steris been receiving favorable news coverage? News stories about STE stock have trended negative recently, InfoTrie Sentiment reports. The research group rates the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Steris earned a daily sentiment score of -2.0 on InfoTrie's scale. They also assigned news articles about the medical equipment provider a news buzz of 8.0 out of 10, indicating that recent media coverage is very likely to have an effect on the stock's share price in the immediate future. Who are some of Steris' key competitors? Some companies that are related to Steris include Edwards Lifesciences (EW), Align Technology (ALGN), Zimmer Biomet (ZBH), COLOPLAST A/S/ADR (CLPBY), Smith & Nephew (SNN), DEMANT A S/ADR (WILYY), MSA Safety (MSA), Wright Medical Group (WMGI), Avanos Medical (AVNS), Inogen (INGN), Wound Management Technologies (WNDM), Establishment Labs (ESTA), RTI Surgical (RTIX), Invacare (IVC) and ConforMIS (CFMS). What other stocks do shareholders of Steris own? Based on aggregate information from My MarketBeat watchlists, some companies that other Steris investors own include Mastercard (MA), Allergan (AGN), Johnson & Johnson (JNJ), Gilead Sciences (GILD), Bausch Health Companies (BHC), JPMorgan Chase & Co. (JPM), Mcdonald's (MCD), Adobe (ADBE), Cisco Systems (CSCO) and Starbucks (SBUX). Who are Steris' key executives? Steris' management team includes the folowing people: Mr. Walter M. Rosebrough Jr., CEO & Pres (Age 65)Mr. Michael J. Tokich, Sr. VP, CFO & Director (Age 50)Mr. Daniel A. Carestio, Chief Operating Officer (Age 46)Mr. John Adam Zangerle, Sr. VP, Gen. Counsel, Sec. & Director (Age 52)Dr. Adrian Vincent Coward, Sr. VP of Healthcare Specialty Services (Age 49) Who are Steris' major shareholders? Steris' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (10.08%), Janus Henderson Group PLC (8.22%), Wellington Management Group LLP (5.36%), WCM Investment Management LLC (2.82%), FMR LLC (1.51%) and Frontier Capital Management Co. LLC (1.25%). Company insiders that own Steris stock include Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View Institutional Ownership Trends for Steris. Which major investors are selling Steris stock? STE stock was sold by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., Janus Henderson Group PLC, Wells Fargo & Company MN, Victory Capital Management Inc., Wellington Management Group LLP, Copeland Capital Management LLC, Federated Investors Inc. PA and Frontier Capital Management Co. LLC. Company insiders that have sold Steris company stock in the last year include Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View Insider Buying and Selling for Steris. Which major investors are buying Steris stock? STE stock was acquired by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, AJO LP, Kornitzer Capital Management Inc. KS, Daiwa Securities Group Inc., ArrowMark Colorado Holdings LLC, JPMorgan Chase & Co., Bank of Montreal Can and OppenheimerFunds Inc.. View Insider Buying and Selling for Steris. How do I buy shares of Steris? Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Steris' stock price today? One share of STE stock can currently be purchased for approximately $135.11. How big of a company is Steris? Steris has a market capitalization of $11.43 billion and generates $2.78 billion in revenue each year. The medical equipment provider earns $304.05 million in net income (profit) each year or $4.89 on an earnings per share basis. Steris employs 12,000 workers across the globe. What is Steris' official website? The official website for Steris is http://www.steris.com/. How can I contact Steris? Steris' mailing address is Rutherford House Stephensons Way Chaddesden, Derby X0, DE21 6LY. The medical equipment provider can be reached via phone at 44-13-3238-7100 or via email at [email protected] MarketBeat Community Rating for Steris (NYSE STE)Community Ranking: 2.0 out of 5 ( )Outperform Votes: 208 (Thanks for Voting!)Underperform Votes: 317 (Thanks for Voting!)Total Votes: 525MarketBeat's community ratings are surveys of what our community members think about Steris and other stocks. Vote "Outperform" if you believe STE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STE will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/26/2019 by MarketBeat.com StaffFeatured Article: Overbought Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.